Hong Min-Hua, Xu Chi, Wang Yu-Jun, Ji Jing-Li, Tao Yi-Min, Xu Xue-Jun, Chen Jie, Xie Xin, Chi Zhi-Qiang, Liu Jing-Gen
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
J Neurochem. 2009 Jan;108(1):102-14. doi: 10.1111/j.1471-4159.2008.05740.x. Epub 2008 Nov 10.
The opioid receptors are a member of G protein-coupled receptors that mediate physiological effects of endogenous opioid peptides and structurally distinct opioid alkaloids. Although it is well characterized that there is differential receptor desensitization and internalization properties following activation by distinct agonists, the underlying mechanisms remain elusive. We investigated the signaling events of delta-opioid receptor (deltaOR) initiated by two ligands, DPDPE and TIPP. We found that although both ligands inhibited adenylyl cyclase (AC) and activated ERK1/2, only DPDPE induced desensitization and internalization of the deltaOR. We further found that DPDPE, instead of TIPP, could activate GRK2 by phosphorylating the non-receptor tyrosine kinase Src and translocating it to membrane receptors. Activation of GRK2 led to the phosphorylation of serine residues in the C-terminal tail, which facilitates beta-arrestin1/2 membrane translocation. Meanwhile, we also found that DPDPE promoted beta-arrestin1 dephosphorylation in a Src-dependent manner. Thus, DPDPE appears to strengthen beta-arrestin function by dual regulations: promoting beta-arrestin recruitment and increasing beta-arrestin dephosphorylation at the plasma membrane in a Src-dependent manner. All effects initiated by DPDPE could be abolished or suppressed by PP2, an inhibitor of Src. Morphine, which has been previously shown to be unable to desensitize or internalize deltaOR, also behaved as TIPP in failure to utilize Src to regulate deltaOR signaling. These findings point to the existence of agonist-specific utilization of Src to regulate deltaOR signaling and reveal the molecular events by which Src modulates deltaOR responsiveness.
阿片受体是G蛋白偶联受体家族的成员,介导内源性阿片肽和结构不同的阿片生物碱的生理效应。尽管已经充分证实,不同激动剂激活后受体脱敏和内化特性存在差异,但其潜在机制仍不清楚。我们研究了由两种配体DPDPE和TIPP引发的δ-阿片受体(δOR)的信号转导事件。我们发现,尽管两种配体都抑制腺苷酸环化酶(AC)并激活ERK1/2,但只有DPDPE诱导δOR脱敏和内化。我们进一步发现,DPDPE而非TIPP可通过磷酸化非受体酪氨酸激酶Src并将其转运至膜受体来激活GRK2。GRK2的激活导致C末端尾巴中丝氨酸残基的磷酸化,这促进了β-抑制蛋白1/2的膜转位。同时,我们还发现DPDPE以Src依赖的方式促进β-抑制蛋白1的去磷酸化。因此,DPDPE似乎通过双重调节增强β-抑制蛋白功能:以Src依赖的方式促进β-抑制蛋白募集并增加质膜上β-抑制蛋白的去磷酸化。DPDPE引发的所有效应都可被Src抑制剂PP2消除或抑制。吗啡先前已被证明无法使δOR脱敏或内化,其作用方式也与TIPP相同,无法利用Src调节δOR信号。这些发现表明存在激动剂特异性利用Src来调节δOR信号,并揭示了Src调节δOR反应性的分子事件。